Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25
In Brief: Search Committee Finds Prospects Uncertain About Election, Unwilling To Take Pay Cut
Intarferon Results Promising, ACS Says, And commits Another $3.4 Million
Randomization With Options Stimulates Sedmental Accrual
It’s Official; Most of NCI NTP contingent Will Move To N.C.
Guidelines Adopted For Pathology Review
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- Survivorship begins at diagnosis—cancer care system must recognize this
- Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy









